Brief Title
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
Official Title
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
Brief Summary
This study looks at how well the Journey Ahead intervention works in improving coping and
communication skills in participants with gynecologic cancers.
Detailed Description
Primary goals of this project are:
Objective 1: Phase 1: To collect feedback from patients on CCI online and to assess patient's
evaluation of CCI online.
Objective 2: Phase 1: To examine the feasibility and acceptability of a CCI online.
Objective 3: Phase 1/2: To collect preliminary data on changes in distress and coping
associated with participation in CCI online.
Study Type
Interventional
Primary Outcome
Depressive symptoms "change" is being assessed
Secondary Outcome
Physical impairment
Condition
Gynecologic Cancer
Intervention
Informational intervention
Study Arms / Comparison Groups
Journey Ahead
Description: Experimental: Journey Ahead intervention focusing on coping and communication skill development during the course of 8 sessions and 6 phone calls.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
30
Start Date
July 14, 2020
Completion Date
December 1, 2024
Primary Completion Date
December 1, 2023
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with any stage of primary ovarian cancer, primary peritoneal cancer, or
primary fallopian tube cancer or experienced a recurrence in the past 5 years;
- Diagnosed with High Grade Stage 2, any grade Stage 3 or higher endometrial cancer or
experienced a recurrence in the past 5 years;
- Diagnosed with Stage 2 or higher cervical cancer or experienced a recurrence within
the past 5 years;
- Diagnosed with any stage Uterine Cancer (both Sarcoma and carcinosarcoma) or
experienced a recurrence in the past 5 years;
- At the time of recruitment the patient has received chemotherapy or radiation in the
past 5 years, or is less than 5 years post-cancer surgery;
- At the time of recruitment, a Karnofsky Performance Status of 80 or above or an
Eastern Cooperative Oncology Group (ECOG) (80) score of 0 or 1;
- 18 years of age or older;
- English speaking;
- Has internet access, able to view the online intervention sessions and attend
telephone or video/telehealth chats to discuss the session content and provide
feedback;
- Must give informed consent within 5 years of diagnosis.
Exclusion Criteria:
-
Gender
Female
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Sharon L Manne, PhD, 732-3577978, [email protected]
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT05220033
Organization ID
Pro2019002089
Responsible Party
Principal Investigator
Study Sponsor
Rutgers, The State University of New Jersey
Study Sponsor
Sharon L Manne, PhD, Principal Investigator, Rutgers Cancer Institute of New Jersey
Verification Date
February 2023